Eversept Partners as of June 30, 2020
Portfolio Holdings for Eversept Partners
Eversept Partners holds 67 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 14.4 | $105M | 340k | 308.36 | |
Horizon Therapeutics Pub SHS | 7.3 | $53M | 955k | 55.58 | |
Tg Therapeutics (TGTX) | 6.7 | $49M | 2.5M | 19.48 | |
Amarin Corp Spons Adr New (AMRN) | 5.6 | $41M | 5.9M | 6.92 | |
Biohaven Pharmaceutical Holding | 4.5 | $33M | 448k | 73.11 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 4.5 | $33M | 220k | 147.90 | |
Astrazeneca Sponsored Adr (AZN) | 4.1 | $30M | 562k | 52.89 | |
United Therapeutics Corporation (UTHR) | 3.9 | $28M | 233k | 121.00 | |
Zogenix Com New | 3.8 | $27M | 1.0M | 27.01 | |
Heska Corp Com Restrc New | 3.6 | $26M | 280k | 93.17 | |
Deciphera Pharmaceuticals | 3.4 | $25M | 419k | 59.72 | |
BioCryst Pharmaceuticals (BCRX) | 3.2 | $23M | 4.8M | 4.76 | |
Danaher Corporation (DHR) | 2.6 | $19M | 108k | 176.99 | |
Fate Therapeutics (FATE) | 2.5 | $18M | 531k | 34.31 | |
Ensign (ENSG) | 2.5 | $18M | 427k | 41.90 | |
Myovant Sciences | 2.2 | $16M | 761k | 20.62 | |
Apellis Pharmaceuticals (APLS) | 1.9 | $14M | 421k | 32.66 | |
Model N (MODN) | 1.6 | $12M | 341k | 34.76 | |
Sarepta Therapeutics (SRPT) | 1.6 | $12M | 72k | 160.34 | |
Glaxosmithkline Sponsored Adr | 1.3 | $9.3M | 227k | 40.79 | |
Celldex Therapeutics Com New (CLDX) | 1.3 | $9.3M | 713k | 13.00 | |
Aurinia Pharmaceuticals (AUPH) | 1.2 | $8.9M | 548k | 16.25 | |
Select Sector Spdr Tr Sbi Healthcare Put Option (XLV) | 1.1 | $8.0M | 80k | 100.07 | |
Liquidia Technologies (LQDA) | 1.0 | $7.2M | 860k | 8.42 | |
Taro Pharmaceutical Inds SHS (TARO) | 1.0 | $7.0M | 105k | 66.49 | |
Pacira Pharmaceuticals (PCRX) | 1.0 | $7.0M | 133k | 52.47 | |
Myokardia | 0.9 | $6.8M | 71k | 96.62 | |
Oxford Immunotec Global Ord Shs | 0.6 | $4.6M | 350k | 13.00 | |
Affimed Therapeutics B V | 0.6 | $4.4M | 943k | 4.62 | |
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.6 | $4.2M | 887k | 4.76 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.6 | $4.1M | 258k | 16.03 | |
Momenta Pharmaceuticals | 0.6 | $4.1M | 124k | 33.27 | |
Qiagen Nv Shs New | 0.5 | $3.5M | 83k | 42.81 | |
Cytokinetics Com New (CYTK) | 0.5 | $3.3M | 142k | 23.57 | |
Dicerna Pharmaceuticals | 0.4 | $3.3M | 129k | 25.40 | |
Radius Health Com New | 0.4 | $3.0M | 220k | 13.63 | |
Hca Holdings (HCA) | 0.4 | $3.0M | 30k | 97.06 | |
Vapotherm | 0.4 | $2.9M | 72k | 40.99 | |
Align Technology Put Option (ALGN) | 0.4 | $2.7M | 10k | 274.44 | |
Dex (DXCM) | 0.4 | $2.7M | 6.7k | 405.40 | |
BioDelivery Sciences International | 0.3 | $2.5M | 584k | 4.36 | |
Sanofi Sponsored Adr (SNY) | 0.3 | $2.5M | 50k | 51.05 | |
Chemocentryx | 0.3 | $2.4M | 41k | 57.54 | |
Concert Pharmaceuticals I equity | 0.3 | $2.3M | 233k | 9.95 | |
Pennant Group (PNTG) | 0.3 | $2.3M | 103k | 22.60 | |
Otonomy | 0.3 | $2.2M | 601k | 3.62 | |
Kiniksa Pharmaceuticals Com Cl A | 0.3 | $2.1M | 82k | 25.48 | |
Albireo Pharma | 0.3 | $2.1M | 78k | 26.49 | |
D Fluidigm Corp Del (LAB) | 0.3 | $1.9M | 468k | 4.01 | |
Scpharmaceuticals (SCPH) | 0.2 | $1.8M | 247k | 7.36 | |
Prothena Corp SHS (PRTA) | 0.2 | $1.6M | 152k | 10.46 | |
Community Health Systems (CYH) | 0.2 | $1.5M | 492k | 3.01 | |
Cyclerion Therapeutics | 0.2 | $1.5M | 248k | 5.91 | |
Zymeworks | 0.2 | $1.4M | 40k | 36.07 | |
Sesen Bio | 0.2 | $1.4M | 2.0M | 0.72 | |
Protara Therapeutics Com Stk (TARA) | 0.2 | $1.4M | 46k | 29.32 | |
Xoma Corp Del Com New (XOMA) | 0.2 | $1.3M | 64k | 19.76 | |
Solid Biosciences | 0.2 | $1.2M | 407k | 2.93 | |
Kalvista Pharmaceuticals (KALV) | 0.1 | $1.1M | 90k | 12.10 | |
Uniqure Nv SHS (QURE) | 0.1 | $1.0M | 23k | 45.06 | |
Dynavax Technologies Corp Com New (DVAX) | 0.1 | $868k | 98k | 8.87 | |
Teligent Com New (TLGTQ) | 0.1 | $859k | 355k | 2.42 | |
Burning Rock Biotech Sponsored Ads | 0.1 | $810k | 30k | 27.01 | |
Air Lease Corp Cl A Put Option (AL) | 0.1 | $586k | 20k | 29.29 | |
Osmotica Pharmaceuticals SHS (RVLPQ) | 0.1 | $532k | 79k | 6.73 | |
Eiger Biopharmaceuticals | 0.1 | $471k | 49k | 9.60 | |
Immunovant (IMVT) | 0.0 | $299k | 12k | 24.35 |